logo.gif
Bavarian Nordic A/S - Articles of Association
03 mai 2021 04h48 HE | Bavarian Nordic A/S
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association ...
Bavarian Nordic A/S - Vedtægter
03 mai 2021 04h48 HE | Bavarian Nordic A/S
Opdaterede vedtægter for Bavarian Nordic A/S. Vedhæftet fil Bavarian Nordic - Vedtægter ...
Bavarian Nordic Reports New Preclinical Data for COVID-19 Vaccine Confirming Potential for Broad Protection against SARS-CoV2 Variants
29 avr. 2021 02h09 HE | Bavarian Nordic A/S
COPENHAGEN, Denmark, April 29, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today reported additional preclinical data for the capsid virus-like particle (cVLP) COVID-19 vaccine candidate,...
Bavarian Nordic rapporterer nye prækliniske resultater for COVID-19 vaccine, der bekræfter potentiale for bred beskyttelse mod SARS-CoV2-virusvarianter
29 avr. 2021 02h09 HE | Bavarian Nordic A/S
KØBENHAVN, Danmark, 29. april 2021 – Bavarian Nordic A/S (OMX: BAVA) rapporterede i dag yderligere prækliniske resultater for COVID-19 vaccinekandidaten, ABNCoV2, som er baseret på en capsid virus...
logo.gif
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held April 20, 2021
20 avr. 2021 12h36 HE | Bavarian Nordic A/S
COPENHAGEN, Denmark, April 20, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held the Annual General Meeting with the results as follows: The Annual Report for 2020 was adopted. The Board...
Bavarian Nordic A/S – Orientering om forløb af ordinær generalforsamling den 20. april 2021
20 avr. 2021 12h36 HE | Bavarian Nordic A/S
KØBENHAVN, Danmark, 20. april 2021 – Bavarian Nordic A/S (OMX: BAVA) har i dag afholdt ordinær generalforsamling med følgende resultater: Årsrapporten for 2020 blev godkendt. Bestyrelsens forslag om,...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
17 avr. 2021 06h00 HE | Bavarian Nordic A/S
COPENHAGEN, Denmark, April 17, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
17 avr. 2021 06h00 HE | Bavarian Nordic A/S
KØBENHAVN, Danmark, 17. april 2021 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
logo.gif
Bavarian Nordic Receives Order to Manufacture Additional Ebola Vaccines
06 avr. 2021 05h17 HE | Bavarian Nordic A/S
COPENHAGEN, Denmark, April 6, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has received a new supply order from Janssen Pharmaceutica NV, part of the Janssen...
Bavarian Nordic modtager ordre på produktion af yderligere ebolavacciner
06 avr. 2021 05h17 HE | Bavarian Nordic A/S
KØBENHAVN, Danmark, 6. april 2021 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har modtaget en ny ordre fra Janssen Pharmaceutica NV, en del af Janssen Pharmaceutical Companies of...